Gary L. Davis

21.0k citations
234 papers · 16.3k indexed · 7 hit papers · h-index 65

Impact in

  • Hepatology top 0.02%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver Diseases and Immunity
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Epidemiology top 0.05%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 116
    • Liver Disease and Transplantation 33
    • Liver Diseases and Immunity 16
    • Hepatocellular Carcinoma Treatment and Prognosis 11
    • Liver Disease Diagnosis and Treatment 93
    • Hepatitis B Virus Studies 77

Gary L. Davis

225 papers receiving 15.6k citations

Hit Papers

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression 2009 · 673 citations
67319892026200120134008001.2k

Peers

Gary L. Davis
Comparison fields: 5 of 175
  • Hepatology 11.6k
  • Epidemiology 10.6k
  • Transplantation 372
  • Rheumatology 1.6k
  • Virology 325
Replace Thomas Berg with:
Thomas Berg Germany
Teresa L. Wright United States
Ansgar W. Lohse Germany
Howard C. Thomas United Kingdom
Aftab A. Ansari United States
Graham R. Foster United Kingdom
Dorothy H. Crawford Australia
A. Albertí Italy
Ming‐Lung Yu Taiwan
Hubert E. Blum Germany
Gary L. Davis relative to Thomas Berg Germany Thomas Berg's profile →
Citations per field
00.5×1.5×
Thomas Berg · 1×
Citations per year

Countries citing papers authored by Gary L. Davis

Since Specialization
Citations

This map shows the geographic impact of Gary L. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. Davis more than expected).

Fields of papers citing papers by Gary L. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. Davis. The network helps show where Gary L. Davis may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary L. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary L. Davis Line = papers co-authored together Gary L. Davis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202010
2 2009106
3 200912
4 200811
5 2005103
6 200519
7
Ethics: An Educational Imperative.
20040
8
The law of remedies in the second half of the twentieth century: an Australian perspective
20040
9 200315
10
Defamation and Satire: Hanson v Australian Broadcasting Corporation
20011
11
John Pfeiffer Pty Ltd v Rogerson: choice of law in tort at the dawning of the 21st century: case notes
20001
12 199921
13
Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C
Hit paper breakdown →
19981070
14 199722
15 199713
16 1997112
17 199516
18 19933
19 19868
20
A Content Analysis of Fifty-Seven Children's Books With Death Themes.
19865

About Gary L. Davis

Gary L. Davis is a scholar working on Hepatology, Epidemiology, Transplantation, Rheumatology and Law, having authored 234 papers that have together received 16.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (116 papers), Liver Disease Diagnosis and Treatment (93 papers), Hepatitis B Virus Studies (77 papers), Liver Disease and Transplantation (33 papers), Systemic Lupus Erythematosus Research (24 papers), Liver Diseases and Immunity (16 papers), Organ Transplantation Techniques and Outcomes (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (11 papers). The work is most often cited by research in Hepatology (11.6k citations), Epidemiology (10.6k citations), Transplantation (372 citations), Rheumatology (1.6k citations) and Virology (325 citations). Gary L. Davis has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Johnson Y.N. Lau, Janice K. Albrecht, Linda W. Jennings, Johnson Y. N. Lau, David R. Nelson, Karen L. Lindsay, Thierry Poynard, Jay H. Hoofnagle, Göran B. Klintmalm and John G. McHutchison. Their work appears in journals such as Hepatology, Gastroenterology, Liver Transplantation, Journal of Viral Hepatitis and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026